Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a888a536389af4a49ebdc2c36de65848 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4716 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-326 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-515 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6887 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate |
2018-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f16e58740a24ac0f16d0b9885e75e2d1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc18dc3ec701fb3af0dc63b6eaeea431 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8be4f9a1ab5bcd0ee27579c677fe5e5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef8509d8b1bc07adb88b3697d322af4a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5367b66577bfb6a3cb4f3368ee52aaf6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d37ed63c609af71fd09cad710630a736 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4dce9fc64f2a3dd14e58a21881ff584c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3de2fda3c2859b4e2332540e59138e0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c82256cf030630a6276995b26339e908 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6980082206ac314df356e56bf222035e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c331f172ea1526bb87c99893f40f4ed http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df886b47a2e0603b79be89b5f44a50e7 |
publicationDate |
2019-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2019353666-A1 |
titleOfInvention |
Circulating angiopoietin-2 (ang-2) for the prediction of recurrence of atrial fibrillation |
abstract |
The present disclosure relates to a method for predicting the risk of recurrence of Atrial Fibrillation in a subject based on determining the amount of the biomarker Angiopoietin-2 (Ang-2) and optionally of at least one further biomarker in a sample from the subject. The present disclosure also contemplates a method of diagnosing Atrial Fibrillation in a subject suspected to suffer from Atrial Fibrillation based on determining the amount of the biomarker Angiopoietin-2 (Ang-2) and optionally of at least one further biomarker in a sample from the subject. Further envisaged are devices adapted to carry out the method of the present disclosure. |
priorityDate |
2016-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |